Loading...
Loading...
RPID| Name | Value |
|---|---|
| Revenues | 5.6M |
| Cost of Revenue | 7.1M |
| Gross Profit | -1.5M |
| Operating Expense | 12.8M |
| Operating I/L | -14.3M |
| Other Income/Expense | 1.0M |
| Interest Income | 1.0M |
| Pretax | -13.3M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -13.3M |
Rapid Micro Biosystems, Inc. provides innovative products for the detection of microbial contamination in pharmaceutical, medical device, and personal care product manufacturing. Their Growth Direct platform automates and modernizes manual microbial quality control testing workflows for various therapeutic modalities, including biologics, vaccines, cell and gene therapies, and sterile injectables. The platform includes the Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Rapid Micro Biosystems also offers installation and verification, technical training, and support services for their solutions, which are utilized in environmental monitoring, water testing, bioburden, and sterility release testing applications.
